Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional...

von Vugmeyster, Yulia
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2004)